Evidence map›Paper›PMID 28819873›Full record

ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2018

Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations.

B A Cunha, J Baron, C B Cunha

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Review
  3. Doxycycline: An essential tool for Alzheimer's disease.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Oral doxycycline to carbapenem-resistant Acinetobacter baumannii infection as a polymyxin-sparing strategy: results from a retrospective cohort.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  9. Omadacycline Is Highly ActiveMicrobiology spectrum · 2022
    Article
  10. Article
  11. Can tetracyclines ensure help in multiple sclerosis immunotherapy?Journal of clinical and translational research · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Sarecycline: A Review of Preclinical and Clinical Evidence.Clinical, cosmetic and investigational dermatology · 2020
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

B A CunhaInfectious Disease Division, Winthrop-University Hospital, 22 Station Plaza North (#432), Mineola, NY, 11501, USA. bacunha@winthrop.org.
J BaronPharmacy Department, Roswell Park Cancer Institute, Buffalo, NY, USA.
C B CunhaInfectious Disease Division, Rhode Island Hospital and The Miriam Hospital, Providence, RI, USA.
Miriam Hospital · USRoswell Park Comprehensive Cancer Center · USWinthrop-University Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Doxycycline and, to a lesser extent, minocycline, have been used for decades to treat various serious systemic infections, but many physicians remain unfamiliar with their spectrum, interpretation of susceptibility results, pharmacokinetic/pharmacodynamic (PK/PD) properties, optimal dosing regimens, and their activity against MRSA, VRE, and multidrug-resistant (MDR) Gram-negative bacilli, e.g., Acinetobacter sp. This article reviews the optimal use of doxycycline and minocycline to treat a variety of infections and when minocycline is preferred instead of doxycycline.

Indexed as

AcinetobacterAcinetobacter InfectionsAnti-Bacterial AgentsAntimicrobial StewardshipDisk Diffusion Antimicrobial TestsDoxycyclineDrug Resistance, Multiple, BacterialHumansMinocyclineStreptococcusVancomycin-Resistant EnterococciAnti-Bacterial AgentsDoxycyclineMinocycline

Identifiers

PMID28819873
OpenAlexW2745840306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.